lipoxin a4 has been researched along with resolvin d1 in 29 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (10.34) | 29.6817 |
2010's | 21 (72.41) | 24.3611 |
2020's | 5 (17.24) | 2.80 |
Authors | Studies |
---|---|
Campbell, E; Colgan, SP; Gotlinger, K; Oh, SF; Petasis, NA; Serhan, CN; Sun, YP; Uddin, J; Yang, R | 1 |
Baumgart, DC; Kang, JX; Weylandt, KH; Wiedenmann, B | 1 |
Chan, L; Gotlinger, KH; Ko, K; Merched, AJ; Serhan, CN | 1 |
Antony, R; Arita, M; Bazan, NG; Hong, S; Marcheselli, VL; Mukherjee, PK; Petasis, NA; Serhan, CN; Sheets, K; Winkler, JW | 1 |
Flower, RJ; Norling, LV; Perretti, M; Serhan, CN; Spite, M; Yang, R | 1 |
Arthur, GK; Bradding, P; Brightling, CE; Jones, DJ; Martin, N; Pavord, ID; Ruddick, A; Wan, H; Woodman, L | 1 |
Dalli, J; Dimisko, L; Irimia, D; Jones, CN; Serhan, CN; Wong, E | 1 |
Bolstad, AI; Hasturk, H; Kantarci, A; Lygre, H; Mustafa, K; Mustafa, M; Serhan, C; Van Dyke, TE; Zarrough, A | 1 |
Abdelhamid, Ael-D; Abdelmoaty, S; Bas, DB; Brodin, E; Codeluppi, S; El-Awady, el-S; Fernandez-Zafra, T; Moustafa, Y; Svensson, CI; Wigerblad, G | 1 |
Lee, CH; Lee, EJ; Lee, HJ; Park, MK | 1 |
Cortés-Toro, V; Eriksdotter, M; Eyjolfsdottir, H; Fitzgerald, JM; Graff, C; Granholm, AC; Hjorth, E; Nennesmo, I; Palmblad, J; Sambamurti, K; Schultzberg, M; Serhan, CN; Wang, X; Zhu, M | 1 |
Freedman, SD; Gilkey, C; Hasturk, H; Kantarci, A; Martin, CR; Salguero, MV; Van Dyke, TE; Zaman, MM | 1 |
Bao, JJ; Ding, H; Hu, C; Liu, XC; Mei, Q; Xu, JM; Zhao, XW | 1 |
Águas, AP; Amaral, IF; Barbosa, JN; Barbosa, MA; Costa, M; Vasconcelos, DP | 1 |
Angioni, C; Ball, AK; Basavarajappa, D; Blöcher, R; Ferreirós, N; Geisslinger, G; Haeggström, JZ; Häfner, AK; Homann, J; Kahnt, AS; Kleinschmidt, TK; Lehmann, C; Parnham, MJ; Proschak, E; Rådmark, O; Steinhilber, D | 1 |
Bannenberg, G; Boscá, L; Cuadrado, A; Fernández-Velasco, M; López-Collazo, E; Martín-Sanz, P; Prieto, P; Rosales-Mendoza, CE; Terrón, V; Toledano, V | 1 |
Baker, OJ; Melvin, JE; Wang, CS; Wee, Y; Yang, CH | 1 |
Blumberg, N; Lannan, KL; Phipps, RP; Spinelli, SL | 1 |
Dartt, DA; English, JT; Hodges, RR; Norris, PC; Serhan, CN | 1 |
Aloia, T; Cata, JP; Conrad, C; Gottumukkala, V; Kim, BJ; Ramirez, MF; Vauthey, JN; Velasquez, JF | 1 |
Colas, RA; Dalli, J; De Maeyer, RP; Flint, JD; George, MJ; Gilroy, DW; Motwani, MP; Richard-Loendt, A; Serhan, CN | 1 |
Bielenberg, DR; Gartung, A; Gilligan, MM; Huang, S; Kieran, MW; Norris, PC; Panigrahy, D; Serhan, CN; Sukhatme, VP; Sulciner, ML | 1 |
Chen, YC; Chin, CH; Hsiao, CC; Hsu, PY; Huang, KT; Lin, IC; Lin, MC; Lin, YY; Liou, CW; Su, MC; Wang, TY; Zheng, YX | 1 |
Gu, Y; Lu, J; Qin, Y; Song, Z; Wei, J; Xiong, Y; Zhu, Y | 1 |
Dec, K; Drozd, A; Jakubczyk, K; Maciejewska, D; Pilutin, A; Skonieczna-Żydecka, K; Skórka-Majewicz, M; Stachowska, E | 1 |
Akgül, Ö; Özdemir, AT; Özgül Özdemir, RB; Soysal Gündüz, Ö | 1 |
Croze, RH; Fang, X; Gotts, JE; Matthay, MA; Siegel, ER | 1 |
Alpoim, PN; Barbosa, AS; da Silva, SPG; de Castro Pinto, KM; de Sousa, LP; Dusse, LMS; Lage, EM; Perucci, LO; Talvani, A; Teixeira, PG | 1 |
Özdemir, AT; Yücel, H | 1 |
1 review(s) available for lipoxin a4 and resolvin d1
Article | Year |
---|---|
Lipoxins and resolvins in inflammatory bowel disease.
Topics: Animals; Anti-Inflammatory Agents; Disease Models, Animal; Docosahexaenoic Acids; Eicosapentaenoic Acid; Humans; Inflammatory Bowel Diseases; Lipoxins; Treatment Outcome | 2007 |
3 trial(s) available for lipoxin a4 and resolvin d1
Article | Year |
---|---|
Effect of diclofenac on the levels of lipoxin A4 and Resolvin D1 and E1 in the post-ERCP pancreatitis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cholangiopancreatography, Endoscopic Retrograde; Diclofenac; Docosahexaenoic Acids; Eicosapentaenoic Acid; Humans; Lipoxins; Pancreatitis | 2014 |
Inflammation and pro-resolution inflammation after hepatobiliary surgery.
Topics: Aged; Anti-Inflammatory Agents; Biliary Tract Surgical Procedures; Colorectal Neoplasms; Docosahexaenoic Acids; Female; Hepatectomy; Humans; Hydrocortisone; Inflammation; Interleukin-6; Lipoxins; Liver Neoplasms; Male; Middle Aged; Perioperative Period; Postoperative Complications; Prognosis; Time Factors; Treatment Outcome | 2017 |
Longitudinal assessment of leukotriene B4, lipoxin A4, and resolvin D1 plasma levels in pregnant women with risk factors for preeclampsia.
Topics: Adolescent; Adult; Docosahexaenoic Acids; Female; Humans; Leukotriene B4; Lipoxins; Longitudinal Studies; Pre-Eclampsia; Pregnancy; Risk Factors | 2021 |
25 other study(ies) available for lipoxin a4 and resolvin d1
Article | Year |
---|---|
Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cell Line; Cell Migration Inhibition; Docosahexaenoic Acids; Enzyme Inhibitors; Humans; Male; Mice; Neutrophil Infiltration; Stereoisomerism | 2007 |
Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators.
Topics: Animals; Apolipoproteins E; Arachidonate 12-Lipoxygenase; Arachidonate 15-Lipoxygenase; Atherosclerosis; Docosahexaenoic Acids; Endothelium, Vascular; Humans; Interleukins; Lipoxins; Macrophages; Mice; Mice, Knockout; Vasculitis | 2008 |
Neuroprotectin D1/protectin D1 stereoselective and specific binding with human retinal pigment epithelial cells and neutrophils.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Apoptosis; Binding, Competitive; Cell Line; Docosahexaenoic Acids; Dose-Response Relationship, Drug; Eicosapentaenoic Acid; Epoxy Compounds; Humans; Hydrogen Peroxide; Isomerism; Kinetics; Lipoxins; Neuroprotective Agents; Neutrophils; Oxidative Stress; Retinal Pigment Epithelium; Tumor Necrosis Factor-alpha | 2010 |
Cutting edge: Humanized nano-proresolving medicines mimic inflammation-resolution and enhance wound healing.
Topics: Animals; Anti-Inflammatory Agents; Aspirin; Cell Movement; Chromatography, Liquid; Docosahexaenoic Acids; Humans; Inflammation; Keratinocytes; Lipids; Lipoxins; Male; Mice; Microspheres; Molecular Mimicry; Nanoparticles; Neutrophils; Peritonitis; Tandem Mass Spectrometry; Temporomandibular Joint; Temporomandibular Joint Disorders; Wound Healing | 2011 |
Primary human airway epithelial cell-dependent inhibition of human lung mast cell degranulation.
Topics: Asthma; Cell Degranulation; Cells, Cultured; Coculture Techniques; Docosahexaenoic Acids; Epithelial Cells; Histamine Release; Humans; Immunoglobulin E; Inflammation Mediators; Limit of Detection; Lipoxins; Lung; Mast Cells; Paracrine Communication; Pertussis Toxin; Receptors, Prostaglandin E, EP2 Subtype; Respiratory Mucosa; Xanthones | 2012 |
Microfluidic chambers for monitoring leukocyte trafficking and humanized nano-proresolving medicines interactions.
Topics: Cell Movement; Chemotaxis, Leukocyte; Docosahexaenoic Acids; Equipment Design; Humans; Inflammation; Leukocytes; Lipoxins; Microfluidic Analytical Techniques; Monocytes; Nanotechnology; Neutrophils; Pancreatic Elastase | 2012 |
Resolvin D1 protects periodontal ligament.
Topics: Anti-Inflammatory Agents; Cell Movement; Cell Proliferation; Cells, Cultured; Dinoprostone; Docosahexaenoic Acids; Fibroblasts; Humans; Inflammation; Interleukin-1beta; Lipoxins; Monocytes; Periodontal Ligament; Tumor Necrosis Factor-alpha; Up-Regulation; Wound Healing | 2013 |
Spinal actions of lipoxin A4 and 17(R)-resolvin D1 attenuate inflammation-induced mechanical hypersensitivity and spinal TNF release.
Topics: Adaptor Proteins, Signal Transducing; Animals; Anti-Inflammatory Agents; Astrocytes; Cells, Cultured; Cytokines; Docosahexaenoic Acids; Edema; Humans; Hypersensitivity; Inflammation; Interferon-gamma; Lipoxins; Male; Mitogen-Activated Protein Kinases; Rats; Rats, Sprague-Dawley; Receptors, Lipoxin; Spinal Cord; Tumor Necrosis Factor-alpha | 2013 |
Resolvin D1 inhibits TGF-β1-induced epithelial mesenchymal transition of A549 lung cancer cells via lipoxin A4 receptor/formyl peptide receptor 2 and GPR32.
Topics: Cell Line, Tumor; Docosahexaenoic Acids; Epithelial-Mesenchymal Transition; Humans; Lipoxins; Lung Neoplasms; Receptors, Formyl Peptide; Receptors, G-Protein-Coupled; RNA, Small Interfering; Transfection; Transforming Growth Factor beta1 | 2013 |
Resolution of inflammation is altered in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Case-Control Studies; Cognitive Dysfunction; Docosahexaenoic Acids; Female; Hippocampus; Humans; Inflammation; Inflammation Mediators; Lipoxins; Lipoxygenase; Male; Middle Aged; Receptors, Formyl Peptide; Receptors, Lipoxin; tau Proteins | 2015 |
Resolvin D1 and lipoxin A4 improve alveolarization and normalize septal wall thickness in a neonatal murine model of hyperoxia-induced lung injury.
Topics: Animals; Animals, Newborn; Disease Models, Animal; Docosahexaenoic Acids; Female; Hyperoxia; Lipoxins; Lung Injury; Male; Mice; Mice, Inbred C57BL; Pulmonary Alveoli | 2014 |
Modulation of the inflammatory response to chitosan through M2 macrophage polarization using pro-resolution mediators.
Topics: Animals; Biomarkers; Cell Polarity; Chitosan; Cytokines; Decapodiformes; Docosahexaenoic Acids; Flow Cytometry; Implants, Experimental; Inflammation; Lipoxins; Macrophages; Male; Mice, Inbred BALB C | 2015 |
Lipoxin and resolvin biosynthesis is dependent on 5-lipoxygenase activating protein.
Topics: 5-Lipoxygenase-Activating Proteins; Arachidonate 5-Lipoxygenase; Cell Line, Tumor; Cytosol; Docosahexaenoic Acids; Group IV Phospholipases A2; HEK293 Cells; Humans; Indoles; Lipoxins; Macrophages; Neutrophils; Recombinant Proteins | 2015 |
Activation of autophagy in macrophages by pro-resolving lipid mediators.
Topics: Animals; Apoptosis; Autophagy; Cytokines; Docosahexaenoic Acids; Half-Life; Inflammation; Lipoxins; Macrophages; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout | 2015 |
ALX/FPR2 Modulates Anti-Inflammatory Responses in Mouse Submandibular Gland.
Topics: Animals; Apoptosis; Aquaporin 5; Cytokines; Docosahexaenoic Acids; Down-Regulation; Female; Inflammation; Leukocytes; Lipopolysaccharides; Lipoxins; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microscopy, Fluorescence; Receptor, Muscarinic M3; Receptors, Formyl Peptide; Submandibular Gland; Tight Junctions; Up-Regulation; Xerostomia | 2016 |
Maresin 1 induces a novel pro-resolving phenotype in human platelets.
Topics: Adaptor Proteins, Signal Transducing; Blood Platelets; Cardiovascular Diseases; Docosahexaenoic Acids; Hemostasis; Humans; Inflammation; Lipoxins; Myocardial Infarction; Phenotype; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Receptors, G-Protein-Coupled | 2017 |
Identification and Profiling of Specialized Pro-Resolving Mediators in Human Tears by Lipid Mediator Metabolomics.
Topics: Adolescent; Adult; Child, Preschool; Chromatography, Liquid; Docosahexaenoic Acids; Female; Humans; Leukotriene A4; Lipoxins; Male; Metabolomics; Middle Aged; Principal Component Analysis; Prostaglandins; Sex Characteristics; Tandem Mass Spectrometry; Tears; Young Adult | 2017 |
Pro-resolving mediators promote resolution in a human skin model of UV-killed Escherichia coli-driven acute inflammation.
Topics: Adaptor Proteins, Signal Transducing; Adolescent; Adult; Anti-Inflammatory Agents; Blister; Chemokines; Cytokines; Docosahexaenoic Acids; Eicosanoids; Eicosapentaenoic Acid; Escherichia coli; Humans; Inflammation; Leukocytes; Lipoxins; Male; Middle Aged; Neutrophils; Receptors, Chemokine; Receptors, Formyl Peptide; Receptors, G-Protein-Coupled; Receptors, Lipoxin; Skin; Volunteers; Young Adult | 2018 |
Aspirin-triggered proresolving mediators stimulate resolution in cancer.
Topics: Animals; Antineoplastic Agents; Aspirin; Chemokine CCL2; Chemokines; Cytokines; Disease Models, Animal; Docosahexaenoic Acids; Eicosanoids; Fatty Acids, Unsaturated; Female; Inflammation; Lipoxins; Macrophages; Metabolomics; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Microtubule-Associated Proteins; Neoplasm Metastasis; Neoplasms; Nerve Tissue Proteins; Phagocytosis; Plasminogen Inactivators; Prostaglandins | 2019 |
Formyl peptide receptor 1 up-regulation and formyl peptide receptor 2/3 down-regulation of blood immune cells along with defective lipoxin A4/resolvin D1 production in obstructive sleep apnea patients.
Topics: Blood Cells; Case-Control Studies; Cross-Sectional Studies; Docosahexaenoic Acids; Female; Gene Expression Regulation; Humans; Lipoxins; Male; Middle Aged; Monocytes; Neutrophils; Receptors, Formyl Peptide; Receptors, Lipoxin; Sleep Apnea, Obstructive | 2019 |
Effect of chiropractic manipulation on disrupted epithelium barrier and its mechanism of specialized pro-resolving mediators in a spleen-deficiency murine model.
Topics: Animals; Arachidonic Acid; Body Weight; Docosahexaenoic Acids; Epithelium; Gene Expression Regulation; Interferon-gamma; Interleukin-4; Jejunum; Lipoxins; Lung; Male; Manipulation, Chiropractic; Rats; Rats, Sprague-Dawley; RNA, Messenger; Spleen; Zonula Occludens-1 Protein | 2019 |
Eicosanoids in Nonalcoholic Fatty Liver Disease (NAFLD) Progression. Do Serum Eicosanoids Profile Correspond with Liver Eicosanoids Content during NAFLD Development and Progression?
Topics: Animals; Biomarkers; Chromatography, Liquid; Dinoprostone; Disease Models, Animal; Disease Progression; Docosahexaenoic Acids; Eicosanoids; Eicosapentaenoic Acid; Hydroxyeicosatetraenoic Acids; Linoleic Acids; Lipoxins; Liver; Male; Non-alcoholic Fatty Liver Disease; Rats; Rats, Sprague-Dawley | 2020 |
Low levels of pro-resolving lipid mediators lipoxin-A4, resolvin-D1 and resolvin-E1 in patients with rheumatoid arthritis.
Topics: Adult; Aged; Arthritis, Rheumatoid; Cytokines; Disease Progression; Docosahexaenoic Acids; Eicosapentaenoic Acid; Female; Humans; Inflammation; Inflammation Mediators; Lipid Metabolism; Lipoxins; Male; Middle Aged | 2020 |
Inhibition of the lipoxin A4 and resolvin D1 receptor impairs host response to acute lung injury caused by pneumococcal pneumonia in mice.
Topics: Acute Lung Injury; Animals; Docosahexaenoic Acids; Humans; Inflammation; Lipoxins; Lung; Mice; Permeability; Pneumonia, Pneumococcal; Receptors, Lipoxin; Respiratory Distress Syndrome | 2021 |
Low LXA4, RvD1 and RvE1 levels may be an indicator of the development of hypertension.
Topics: Adult; Arachidonate 15-Lipoxygenase; Blood Pressure; Cholesterol; Docosahexaenoic Acids; Eicosapentaenoic Acid; Fatty Acids, Unsaturated; Female; Follow-Up Studies; Humans; Hypercholesterolemia; Hypertension; Lipoproteins, LDL; Lipoxins; Male; Middle Aged; Oxidation-Reduction; Risk Factors | 2021 |